MEDIFAST INC (MED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 600M 1.2B 1.8B Q3 '21: 1.4B Q4 '21: 1.5B Q1 '22: 1.6B Q2 '22: 1.7B Q3 '22: 1.6B Q4 '22: 1.6B Q1 '23: 1.5B Q2 '23: 1.4B Q3 '23: 1.2B Q4 '23: 1.1B Q1 '24: 897.8M Q2 '24: 770.2M Q3 '24: 674.5M Q4 '24: 602.5M Q1 '25: 543.5M Q2 '25: 480.4M Q3 '25: 429.7M Q4 '25: 385.8M Q1 '26: 346.1M Q2 '26: 316.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 500M 1B 1.5B Q3 '21: 1B Q4 '21: 1.1B Q1 '22: 1.2B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '22: 1.1B Q1 '23: 1.1B Q2 '23: 973.6M Q3 '23: 868.1M Q4 '23: 775.9M Q1 '24: 656.8M Q2 '24: 569.5M Q3 '24: 497.8M Q4 '24: 444.6M Q1 '25: 401.6M Q2 '25: 354.8M Q3 '25: 311.3M Q4 '25: 275.2M Q1 '26: 242.7M Q2 '26: 219.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-80M 0 80M 160M 240M Q3 '21: 207.4M Q4 '21: 216.2M Q1 '22: 218.5M Q2 '22: 206.1M Q3 '22: 199M Q4 '22: 184.8M Q1 '23: 183.2M Q2 '23: 173M Q3 '23: 150.3M Q4 '23: 126.4M Q1 '24: 80.8M Q2 '24: 34.2M Q3 '24: 10.8M Q4 '24: 2.9M Q1 '25: -6.3M Q2 '25: 486K Q3 '25: -5.7M Q4 '25: -14.2M Q1 '26: -16.2M Q2 '26: -19.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-60M 0 60M 120M 180M Q3 '21: 158M Q4 '21: 164M Q1 '22: 164.7M Q2 '22: 156.9M Q3 '22: 151.1M Q4 '22: 143.6M Q1 '23: 141.8M Q2 '23: 132.9M Q3 '23: 119.9M Q4 '23: 99.4M Q1 '24: 67.8M Q2 '24: 29.3M Q3 '24: 7.3M Q4 '24: 2.1M Q1 '25: -7M Q2 '25: 3.6M Q3 '25: 247K Q4 '25: -18.7M Q1 '26: -20M Q2 '26: -25.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 200M 400M 600M Q3 '21: 364.6M Q4 '21: 398.5M Q1 '22: 421.7M Q2 '22: 452.9M Q3 '22: 454.1M Q4 '22: 458.2M Q1 '23: 445.4M Q2 '23: 399.3M Q3 '23: 350.2M Q4 '23: 296.2M Q1 '24: 241.1M Q2 '24: 200.7M Q3 '24: 176.7M Q4 '24: 157.8M Q1 '25: 141.9M Q2 '25: 125.7M Q3 '25: 118.4M Q4 '25: 110.6M Q1 '26: 103.4M Q2 '26: 97.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 80M 160M 240M Q3 '19: 80.4M Q4 '19: 84.3M Q1 '20: 78.3M Q2 '20: 121.3M Q3 '20: 144.5M Q4 '20: 145.2M Q1 '21: 183.8M Q2 '21: 147.1M Q3 '21: 121.8M Q4 '22: 194.6M Q1 '23: 215M Q2 '23: 214.3M Q3 '23: 188.9M Q4 '23: 147.7M Q1 '24: 90.9M Q2 '24: 60.8M Q3 '24: 39.9M Q4 '25: 6.9M Q1 '26: 3.7M Q2 '26: 8.8M Q4 '19 Q3 '20 Q2 '21 Q1 '23 Q4 '23 Q3 '24 Q2 '26

Free Cash Flow TTM

-70M 0 70M 140M 210M Q3 '19: 69.5M Q4 '19: 74.2M Q1 '20: 72.4M Q2 '20: 117.6M Q3 '20: 139.8M Q4 '20: 139.3M Q1 '21: 173.6M Q2 '21: 129.6M Q3 '21: 97.2M Q4 '22: 177.9M Q1 '23: 199.2M Q2 '23: 199.6M Q3 '23: 174.3M Q4 '23: 141.2M Q1 '24: 84.7M Q2 '24: 54.4M Q3 '24: 33.8M Q4 '25: 1.2M Q1 '26: -1.5M Q2 '26: 4M Q4 '19 Q3 '20 Q2 '21 Q1 '23 Q4 '23 Q3 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q1 '20: 11.8M Q2 '20: 11.8M Q3 '20: 11.9M Q1 '21: 11.9M Q2 '21: 11.9M Q3 '21: 11.8M Q1 '22: 11.6M Q2 '22: 11.4M Q3 '22: 11M Q1 '23: 10.9M Q2 '23: 10.9M Q3 '23: 10.9M Q1 '24: 11M Q2 '24: 10.9M Q3 '24: 11M Q1 '25: 10.9M Q2 '25: 11.1M Q3 '25: 11M Q1 '26: 11M Q2 '26: 11.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-5.00 0.00 5.00 10.00 15.00 Q3 '21: 13.34 Q4 '21: 13.89 Q1 '22: 14.02 Q2 '22: 13.48 Q3 '22: 13.19 Q4 '22: 12.71 Q1 '23: 12.79 Q2 '23: 12.14 Q3 '23: 10.99 Q4 '23: 9.11 Q1 '24: 6.20 Q2 '24: 2.68 Q3 '24: 0.66 Q4 '24: 0.19 Q1 '25: -0.64 Q2 '25: 0.33 Q3 '25: 0.02 Q4 '25: -1.71 Q1 '26: -1.83 Q2 '26: -2.33 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.